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ABSTRAK 
 
Penelitian ini dilakukan untuk meningkatkan pertumbuhan benih ikan gurami (Osphronemus goramy) melalui 
imersi dengan hormon pertumbuhan rekombinan ikan gurami (r-OgGH). Imersi dengan larutan mengandung 
badan inklusi dilakukan dengan dosis r-OgGH berbeda, yakni 0 mg/L (kontrol), 10 mg/L, 20 mg/L, dan 30 
mg/L, sekali seminggu selama tiga minggu. Ikan dipelihara selama lima minggu dalam akuarium dengan 
kepadatan 5 ekor/L, dan ikan diberi pakan naupli Artemia dan cacing sutera dua kali sehari secara ad libitum. 
Hasil penelitian menunjukkan bahwa rerata bobot tubuh ikan perlakuan 30 mg/L (0,34 g) adalah sekitar 75% 
lebih tinggi (p<0,05) daripada perlakuan 10 mg/L (0,24 g) dan kontrol (0,19 g). Kelangsungan hidup tertinggi 
diperoleh pada perlakuan 30 mg/L (100%), diikuti oleh perlakuan 20 mg/L (96%), perlakuan 10 mg/L (94%), 
dan kontrol (94%). Dengan demikian, imersi menggunakan hormon pertumbuhan rekombinan dapat digunakan 
untuk meningkatkan pertumbuhan dan kelangsungan hidup benih ikan gurami. 
 
Kata kunci: protein rekombinan, hormon pertumbuhan, imersi, Osphronemus goramy 
 
ABSTRACT 
 
This study was aimed at enhancing the growth of giant gourami Osphronemus goramy fry by immersion with 
recombinant giant gourami growth hormone (r-OgGH). Immersion with solution containing inclusion bodies 
with different doses of r-OgGH, 0 mg/L (control), 10 mg/L, 20 mg/L, and 30 mg/L was performed on weekly 
basis for the first three weeks of experimental period. Fish were reared for five weeks in glass aquaria at a 
stocking density of 7 fish/L, and fed with Artemia nauplii and blood worm twice a day ad libitum. The results 
showed that the average body weight of 30 mg/L r-OgGH treated fish (0.34 g) was 75% higher (p<0.05) than 
those of 10 mg/L (0.24 g) and control (0.19 g). The highest survival was obtained at 30 mg/L r-OgGH 
immersed fish (100%), followed by 20 mg/L (96%) and 10 mg/L treated fish (94%), and control (94%). The 
results indicate that immersion with recombinant growth hormone could be applied to enhance the growth and 
survival of giant gourami juvenile. 
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INTRODUCTION 
 
Giant gourami Osphronemus goramy has 
the highest price compared to that of other 
freshwater species in Indonesia. Production 
of giant gourami is targeted to be 48,900 
metric ton in 2014, or 27% higher than in 
2009 (Ismanadji, 2010). The crucial problem 
to meet the target is giant gourami performs 
slow growth, where it spends about one year 
of rearing to reach its market size of 500 g. 
Hence, a technique to accelerate its growth is 
required. The application of growth 
stimulation technique using recombinant 
growth hormone (rGH) is considered to be an 
advantage approach.  
Advances in recombinant DNA 
technology have offered a way to produce 
large amounts of teleostean growth hormones 
using bacteria Escherichia coli as a vector 
(Sekine et al., 1985; Sato et al., 1989; 
Sugimoto & Yokoo, 1991; Tsai et al., 1995; 
Promdonkoy et al., 2004; Funkenstein et al., 
2005). Furthermore, administration of 
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recombinant fish growth hormone (rGH) has 
been reported to considerably increase the 
growth of finfish (Moriyama & Kawauchi, 
1990; Lin et al., 1995; Tsai et al., 1997; Ben-
Atia et al., 1999; Promdonkoy et al., 2004; 
Funkenstein et al., 2005; Acosta et al., 2009) 
and shellfish (Xu et al., 2000; Moriyama & 
Kawauchi, 2004; Santiesteban et al., 2010). 
Treatment of rGH can also enhance fish 
survival through increasing its resistance to 
disease (Sakai et al., 1997) and stress 
conditions such as salinity (reviewed by 
McCormick, 2001). The used of rGH may 
also increase the growth and survival of giant 
gourami.   
There are three types of giant gourami 
juvenile usually offer as market size, namely 
the size of ‘kuku’ (about 3 cm in total body 
length/BL), ‘jempol’ (BL of ~4 cm), ‘silet’ 
(BL of ~6 cm), and ‘korek’ (BL of ~8 cm). 
Administration of rGH in larval stage is 
suggested to be considerably increasing the 
growth of giant gourami juvenile. Delivery of 
rGH into larval and juvenile of fish is 
generally conducted by immersion bath 
method (Moriyama & Kawauchi, 1990; 
Moriyama et al., 2008; Acosta et al., 2009; 
Santiesteban et al., 2010). This research was 
aimed to stimulate the growth of giant 
gourami fry by administration of 
recombinant giant gourami growth hormone 
(r-OgGH) into 1-day after yolk egg absorbed 
larvae.  
 
MATERIALS AND METHODS 
 
Construction of protein expression vector   
Signal peptide sequence of giant gourami 
growth hormone (Nugroho et al., 2008) was 
predicted using SignalP 3.0 software (http:// 
www.cbs.dtu.dk/services/signalP). Predicted 
nucleotide sequence encoding mature growth 
hormone of giant gourami (OgGH) was 
amplified by PCR using a set primer of Og-
mGH-F (5’-GGATCC CAG CCA ATC ACA 
GAC AGC CAG-3’) and Og-mGH-R (5’-
GAATTC CTA CAG AGT GCA GTT AGC 
TTC TGG-3’), containing Bam HI and Eco 
RI recognition sites (underlined) 
respectively. Subsequently, the PCR products 
were purified and cloned into the pGEM-T 
Easy vector (Promega, Madison, USA). Bam 
HI/Eco RI-double digested OgGH cDNA 
fragment was then ligated into the 
corresponding sites of the expression vector 
pCold-1 (Takara Bio Inc., Japan) driven by 
cspA promoter. The constructed plasmid was 
designated as pCold-1/OgGH (Alimuddin et 
al., 2010). 
 
Production of r-OgGH 
Escherichia coli BL21 (DE3) harboring 
pCold-1/OgGH was inoculated in 4 mL of 
2×YT medium containing 100 µg/mL of 
ampicillin and was incubated overnight at 37 
°C. Approximately 1 µL of bacterial culture 
was transferred into 100 mL of medium 
containing 100 µg/mL and was subjected to 
cold shock treatment by incubating the 
bacterial culture at 15 °C for 30 min. 
Induction of protein synthesis was performed 
by adding 1 mM IPTG (isopropyl-b-D-
thiogalactopyranoside) and subsequently 
incubated at 15 °C for 24 hours. The bacterial 
cells were harvested by centrifugation at 
12,000 rpm for 1 min at 4 °C, then was 
resuspended in phosphate buffer saline (PBS) 
containing 0.1% Triton X-100, and was 
washed twice by the same solution. Bacterial 
cells was lysed by adding 500 µLlysozyme 
(10 mg/mL lysozyme in TE buffer) and was 
incubated at 37 °C for 20 min, or was 
sonicated six times for 30 s on ice. Inclusion 
bodies were collected by centrifugation at 
12,000 rpm for 5 min, and the pellet was 
washed twice by 1 M NaCl containing 1% 
Triton X-100, and then was resuspended in 
PBS containing SDS and β-mercaptoethanol. 
Sample of inclusion bodies solution was 
heated at 100 °C for 10 min, and then was 
chilled on ice and was centrifuged briefly. 
An aliquot of 10 µL was analyzed by SDS-
PAGE with 10% polyacrylamide gel, and 
protein was visualized using Coomassie Blue 
dye. The recombinant protein was stored at -
80 °C until use. 
 
Immersion of recombinant growth 
hormone and fish rearing 
There are three series of immersion 
treatments due to concentration of r-OgGH, 
i.e. 10 mg/L, 20 mg/L, and 30 mg/L 
respectively, and one treatment without r-
OgGH as the control. In amount of 50 fish 
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was used for each treatments including for 
the control treatment. The 50 fish of one day 
after first feeding were subjected to hyper 
osmotic shock of 3.5% NaCl for 2 min (this 
was obtained from our preliminary study), 
and subsequently immersed for 60 min in 
200 mL of r-OgGH solution at different 
concentrations depend on the treatment and 
without r-OgGH as the control. Along with 
the hormone, 0.9% of NaCl and 0.01% of 
BSA were also added to the immersion 
solution. The treatment was performed in 
duplicate and was performed once weekly for 
three weeks.  
Fish were reared for five weeks in 8 L of 
glass aquaria with water temperature of 27±1 
°C, and fed with Artemia nauplii during the 
first week and blood worms for the next four 
weeks. Feeding was conducted twice a day 
ad libitum. Water quality was maintained by 
daily water replacement at a level of 50% for 
the first two weeks, and 80% for the 
remaining three weeks. Fish body weight was 
measured at seven days interval. Fish feeding 
response was observed in the 5
th
 week. 
 
Statistical analysis  
Statistical analysis were performed by 
SPSS 16.0 software package. Differences in 
body weight and growth rate were 
determined by one-way ANOVA followed 
by Duncan’s test at a significance level of 
p=0.05. Survival and fish feeding response 
were descriptively described.  
 
RESULTS 
 
Recombinant growth hormone production 
Inclusion bodies containing recombinant 
giant gourami growth hormone (r-OgGH) 
obtained from 100 mL of bacterial culture 
was about 390 mg in wet weight. Result of 
SDS-PAGE analysis (Fig. 1) showed that E. 
coli BL21 carrying pCold-1/OgGH 
expression vector could produce a relatively 
high level of r-OgGH in the size of about 21 
kDa. 
 
Fish growth  
The changes of body weight of non-
treated control and r-OgGH treated groups 
fish is shown in Fig. 2A. Significant 
increment in body weight of treated fish 
groups, especially those treated with 30 mg/L 
r-OgGH was initially observed on the third 
week of experimental period, and this 
consistently observed until the 3
rd
 week of 
treatment. By the end of experiment, both 20 
and 30 mg/L r-OgGH treated fish body 
weight showed 75% and 64%  higher than 
the control (P<0.05), whereas no significant 
difference (P>0.05) was observed between 
fish treated with 10 was observed between 
fish treated with 10 mg/L r-OgGH (0.24 g) 
and those of control (0.19 g). Furthermore, 
the growth rate of 30 mg/L (2.86%/day) and 
20 mg/L r-OgGH treated fish (2.63%/day) 
was comparable (P>0.05), and both were 
significantly higher (P<0.05) than those of 10 
mg/L r-OgGH treated fish (2.14%/day) and 
the control (1.69%/day). Phenotype of 30 
mg/L r-OgGH treated fish and those of 
control fish after five weeks rearing period 
was shown in Fig. 2B. 
 
 
Fig. 1. SDS-PAGE analysis of inclusion bodies 
containing recombinant giant gourami growth 
hormone (arrow head) separated in 10% SDS-
PAGE gel. Lane 1: inclusion bodies from 
lysozyme-lysed bacterial cells. Lane 2: inclusion 
bodies from sonicated bacterial cells. pC: inclusion 
bodies from bacterial cells carrying pCold-1 empty. 
M: molecular weight marker. 
 
Fish survival  
Recombinant growth hormone (rGH) 
treatment appears to increase the survival of 
giant gourami fry (Table 1). The highest 
survival was shown by the treatment of 30 
mg/L r-OgGH (100%), followed by the 
treatment of 20 mg/L (96%), 10 mg/L (94%), 
and the control (94%). 
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(a) (b) 
Fig. 2. Changes in body weight (g) of giant gourami fry in control (–○–), 10 mg/L (–■–), 20 mg/L (–▲–), and 
30 mg/L recombinant growth hormone-immersed groups fish (–●–) for 5 weeks rearing period (a). Fish (n=50) 
were immersed in the hormone solution for 60 min on weekly basis for the first three of five weeks of 
experimental period. The photograph shows the phenotype of non-treated control and 30 mg/L recombinant 
growth hormone-treated groups of fish after five weeks of rearing period in 8-l aquaria (b). 
 
Table 1. Body weight (g), growth (%) and survival (%) rates of giant gourami fry in control and recombinant 
growth hormone-immersed fish at different doses 
r-OgGH dose treatments (mg/L) Body weight (g) Growth rate (%/day) Survival rate (%) 
0 (control) 0.19±0.001
a
 1.69
a
  94±2.0 
10 0.24±0.023
a
 2.14
b
 94±2.0 
20  0.32±0.012
b
 2.64
c
 96±4.0 
30  0.34±0.004
b
 2.86
c
 100±0.0 
The body weight and survival of fish are given as mean ±SE of duplicated treatments. r-OgGH is recombinant 
giant gourami Osphronemus goramy growth hormone. Different superscript letters in the same column indicate 
significant differences (P<0.05).  
 
 
Fig. 3. Different responses to live food (blood 
worm) of giant gourami with non-treated control 
(A), 10 mg/L (B), 20 mg/L (C), and 30 mg/L 
recombinant growth hormone-treated (D). 
Photographs were taken on the last week of rearing 
period. 
 
Fish feeding response 
Visual observation on fish feeding 
behavior showed that treatment of rGH in 
giant gourami fry could increase the fish 
feeding response. This response was initially 
observed on the second week and 
continuously shown for the remaining weeks 
of experimental period (Fig. 3). Figure 3 also 
shows that the number of fish which response 
to feeding was found to be higher as the 
doses of r-OgGH treatment increases. 
 
DISCUSSION 
 
It is well known that the growth of giant 
gourami is relatively slower than other 
freshwater aquaculture species. Several 
manipulation techniques such as selection 
have been applied as an effort to improve 
fish growth. However, to obtain a significant 
genetic gain this technique is labor intensive 
and time-consuming. Therefore, another 
technique such as the application of 
recombinant growth hormone can be applied 
as an alternative way with a minimum cost 
and time. This experiment showed that 
application of recombinant growth hormone 
r-OgGH for three consecutive weeks with at  
dose of 30 mg/L and 20 mg/L resulted in 
significant increase (p<0,05) of 75% and 
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64% growth rate, respectively, when  
compared to the control. Furthermore, the 
growth was still higher at the end of 
experiment (five weeks) even the treatment 
had been stopped in the third week (Fig. 2A). 
Similar results were also reported in 
salmonid (Moriyama & Kawauchi, 1990), 
striped bass, channel catfish, grass carp 
(Sonnenschein, 2001), abalone (Moriyama & 
Kawauchi, 2004), Nile tilapia, goldfish, and 
common carp (Acosta et al., 2009). 
Inclusion bodies obtained from 100 mL of 
bacterial culture was about 390 mg in wet 
weight. With the dose of 30 mg/L and 20 
mg/L, three times immersion and 250 fish 
can be immersed in 1 L water, so that the 
total numbers of fish that can be treated using 
390 mg recombinant protein were about 
1,080 and 1,600 fish, respectively. The 
number of the treated fish per immersion can 
be increased if its density during the 
treatment is raised to more than 50 fish per 
200 mL, thus improving the efficiency of the 
use of rGH. Increasing the number of treated 
fish however may result in lower growth 
acceleration, therefore an optimum fish 
density for an efficient recombinant growth 
hormone immersion treatment still requires 
further investigation.     
Indonesian farmers  commonly perform 
size grading for giant gourami seed 
production where the price is determined 
based on total body length, i.e. ‘kuku’ ( 2‒3 
cm, IDR 150‒250 in price), ‘jempol’ (3‒4 
cm, IDR 500‒750), and ‘silet’ (5‒6 cm, IDR 
1,500‒2,000). When this grading is applied 
to the result of this experiment at the end of 
the rearing period, it is found that the size of 
fry obtained from the treatment with a dose 
of 30 mg/L r-OgGH was mostly categorized 
into ‘jempol’ size, while non-treated control 
was mostly ‘kuku’ size. Thus, the 
administration of rGH not only shorten the 
time required to obtain fry with ‘jempol’ 
size, but also improves the farmers income as 
the price of this size of fry is  2 times higher 
than the ‘kuku’ size.  
The immersion method has been 
developed in various fish species, fish stages 
(larvae, fry, or juvenile), concentrations and 
GH sources (fish and mammalian origin), 
purities (purified or crude protein), 
frequencies and intervals (once to several 
times immersion, and once to thrice weekly), 
methods and periods of fish rearing. Level of 
growth acceleration is also varied, such as 
63% in grass carp, 45% in channel catfish, 
35.5% in striped bass and 20% in freshwater 
prawn using bovine somatotropin 
(Sonnenschein, 2001), 20% in abalone using 
salmon GH (Moriyama & Kawauchi 2004), 
100% in tilapia juvenile using tilapia GH 
(Acosta et al., 2009) and 42.4% in Pacific 
white shrimp using tilapia GH (Santiesteban 
et al., 2010). In our study, immersion was 
performed using crude protein as inclusion 
bodies containing r-OgGH resulted a 
significant growth enhancement of giant 
gourami larvae approximately 75% at the 
dose treatment of 30 mg/L.   
Survival rate of fish treated by 30 mg/L r-
OgGH was higher compared to that of other 
dose treatments and non-treated control 
(Table 1). Water quality was equally 
maintained among treatments, and no 
pathogen infection was visually observed 
during experiment. Thus, it is more likely 
that increasing of survival rate is due to 
response of r-OgGH treatment. Furthermore, 
increasing in survival of the r-OgGH treated 
fish perhaps as a result of an improved 
resistance of fish to hyperosmotic treatment. 
In fact, administration of ovine GH increase 
survival rate of amago salmon Oncorhynchus 
rhodurus in 32‰ seawater (Miwa & Inui, 
1985). This effect is due to the capacity 
of GH to increase the number and size of gill 
chloride cells, Na
+
,K
+
-ATPase, and the Na
+
, 
K
+
, 2Cl
-
 cotransporter (NKCC), ion 
transporters involved in salt secretion 
(McCormick, 2001), and some of the actions 
of GH are through insulin-like growth factor 
I (Sakamoto & McCormick, 2006). The same 
actions of r-OgGH may also involve in giant 
gourami. In addition, administration of rGH 
enhances resistance of rainbow trout against 
bacterial pathogen Vibrio anguillarum (Sakai 
et al., 1997). This effect is through 
stimulation of innate immune system (Sakai 
et al., 1997; Acosta et al., 2008). A similar 
stimulation effect of r-OgGH may also exist 
against bacterial pathogen infection, and this 
remains to study in future. 
Growth hormone treatment increased 
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appetite of giant gourami juvenile. This was 
clearly seen in fish treated with r-OgGH at a 
dose of 30 mg/L (Fig. 3). Similar response 
had also been reported in channel catfish 
treated by recombinant bovine growth 
hormone (Wilson et al., 1988) and goldfish 
treated with recombinant giant catfish growth 
hormone (Promdonkoy et al., 2004). The 
appetite stimulation that affects feed 
consumption had been suggested as a mainly 
factor in increase of channel catfish growth 
following rGH treatment (Wilson et al., 
1988). This maybe also takes place in growth 
enhancement of r-OgGH-treated giant 
gourami juvenile. In fact, growth rate of 30 
mg/L and 20 mg/L r-OgGH treated fish was 
higher than those of 10 mg/L r-OgGH treated 
fish and non-treated fish (Table 1). 
In conclusion, we have demonstrated the 
growth- and survival-promoting effects of r-
OgGH on giant gourami juvenile following 
immersion. It suggested that the rearing 
period of giant gourami to harvesting period 
can be shorten, and survival of larvae can 
also be improved. To our knowledge, this is 
the first study that has achieved the growth 
enhancement of giant gourami using 
recombinant growth hormone.    
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